NovalGen
Sarah Cook has a wealth of experience in clinical operations, having held various senior roles at companies such as AAVantgarde Bio, NovalGen, and Summit Therapeutics plc. With a background in Applied Biology & Human Biology from the University of Wolverhampton, Sarah has built a solid career in project and trial management within the pharmaceutical industry.
This person is not in any teams
NovalGen
NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond